| Primary |
| Product Used For Unknown Indication |
21.0% |
| Off Label Use |
18.7% |
| Drug Use For Unknown Indication |
12.7% |
| Type 2 Diabetes Mellitus |
11.1% |
| Diabetes Mellitus |
9.1% |
| Type 1 Diabetes Mellitus |
9.1% |
| Hypertension |
3.2% |
| Gestational Diabetes |
2.4% |
| Insulin-requiring Type 2 Diabetes Mellitus |
2.4% |
| Diabetes Mellitus Insulin-dependent |
1.6% |
| Insulin-requiring Type Ii Diabetes Mellitus |
1.6% |
| Asthma |
1.2% |
| Hypersensitivity |
1.2% |
| Hyperthyroidism |
1.2% |
| Diabetes Mellitus Non-insulin-dependent |
0.8% |
| Dyslipidaemia |
0.8% |
| Epilepsy |
0.8% |
| Abortion |
0.4% |
| Blood Pressure |
0.4% |
| Cataract |
0.4% |
|
| Victim Of Homicide |
20.6% |
| Homicide |
15.3% |
| Victim Of Crime |
8.4% |
| Death |
6.1% |
| Intentional Drug Misuse |
5.3% |
| Physical Assault |
5.3% |
| Suicide Attempt |
5.3% |
| Hypoglycaemia |
4.6% |
| Product Quality Issue |
3.8% |
| Victim Of Child Abuse |
3.8% |
| Coronary Artery Bypass |
2.3% |
| Diabetic Ketoacidosis |
2.3% |
| Enteritis |
2.3% |
| Overdose |
2.3% |
| Palpitations |
2.3% |
| Pneumonia |
2.3% |
| Premature Baby |
2.3% |
| Rash Generalised |
2.3% |
| Blood Glucose Increased |
1.5% |
| Blood Insulin Increased |
1.5% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
25.8% |
| Hypertension |
13.6% |
| Diabetes Mellitus |
11.4% |
| Product Used For Unknown Indication |
11.4% |
| Insulin-requiring Type 2 Diabetes Mellitus |
9.1% |
| Drug Use For Unknown Indication |
7.6% |
| Diabetes Mellitus Insulin-dependent |
6.8% |
| Partial Seizures |
2.3% |
| Colon Cancer |
1.5% |
| Diabetic Foot |
1.5% |
| Dyslipidaemia |
1.5% |
| Epilepsy |
1.5% |
| Blood Pressure |
0.8% |
| Calcium Deficiency |
0.8% |
| Cardiac Failure |
0.8% |
| Drug Therapy |
0.8% |
| Electrolyte Imbalance |
0.8% |
| Ill-defined Disorder |
0.8% |
| Magnesium Deficiency |
0.8% |
| Multiple Myeloma |
0.8% |
|
| Respiratory Failure |
14.3% |
| Parathyroid Tumour Benign |
11.9% |
| Vomiting |
11.9% |
| Hypoglycaemia |
7.1% |
| Withdrawal Syndrome |
7.1% |
| Injection Site Rash |
4.8% |
| Myocardial Infarction |
4.8% |
| Product Quality Issue |
4.8% |
| Pulmonary Oedema |
4.8% |
| Ventricular Fibrillation |
4.8% |
| Chronic Lymphocytic Leukaemia |
2.4% |
| Convulsion |
2.4% |
| Device Malfunction |
2.4% |
| Drug Interaction |
2.4% |
| Fall |
2.4% |
| Hyperglycaemia |
2.4% |
| Hyperparathyroidism Primary |
2.4% |
| Hypoglycaemic Coma |
2.4% |
| Medication Error |
2.4% |
| Overdose |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
49.2% |
| Product Used For Unknown Indication |
16.0% |
| Diabetes Mellitus |
6.2% |
| Hypertension |
5.2% |
| Renal Failure Chronic |
2.5% |
| Peritoneal Dialysis |
2.4% |
| Rheumatoid Arthritis |
2.1% |
| Type 2 Diabetes Mellitus |
2.0% |
| Chronic Lymphocytic Leukaemia |
1.9% |
| Ill-defined Disorder |
1.6% |
| Pain |
1.4% |
| Hepatic Neoplasm Malignant |
1.3% |
| Nausea |
1.3% |
| Prophylaxis |
1.2% |
| Type 1 Diabetes Mellitus |
1.1% |
| Arthritis Bacterial |
1.0% |
| Coronary Artery Disease |
1.0% |
| Hyperlipidaemia |
1.0% |
| Insomnia |
0.9% |
| Asthma |
0.9% |
|
| Renal Failure Acute |
11.0% |
| Cardiac Arrest |
10.1% |
| Vomiting |
9.3% |
| Myocardial Infarction |
7.5% |
| Rhabdomyolysis |
7.5% |
| Dyspnoea |
7.0% |
| Hypoglycaemia |
5.3% |
| Sepsis |
5.3% |
| Renal Failure |
4.8% |
| Death |
3.5% |
| Urinary Retention |
3.5% |
| Drug Interaction |
3.1% |
| Somnolence |
3.1% |
| Wheezing |
3.1% |
| Fall |
2.6% |
| Loss Of Consciousness |
2.6% |
| Pulmonary Embolism |
2.6% |
| Skin Ulcer |
2.6% |
| Syncope |
2.6% |
| Thrombosis |
2.6% |
|
